Boehringer Ingelheim achieves good growth in the first half of 2017

Boehringer Ingelheim (Canada) Ltd. named as Hamilton-Niagara Top Employer 2018

Boehringer Ingelheim: A New World Leader in Animal Health

Boehringer Ingelheim: Growth in all core businesses

Sanofi and Boehringer Ingelheim have reached definitive agreements to swap Sanofi’s Animal Health and Boehringer Ingelheim’s Consumer Healthcare businesses

Boehringer Ingelheim has a successful 2015 financial year

AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds

Sanofi and Boehringer Ingelheim Enter Exclusive Negotiations on Business Swap

Change in Board of Managing Directors to ensure continuity and focus on the future

Expansion of the Boehringer Ingelheim Board of Managing Directors / Andreas Neumann responsible for Human Resources

Boehringer Ingelheim experiences slight growth in local currency terms in the first half of 2015

2014: Boehringer Ingelheim positioned for future growth with product launches

First half year 2014: Boehringer Ingelheim meets challenges 

Boehringer Ingelheim Establishes a Research Alliance with the University of Toronto, the Toronto-based University Health Network and the Mount Sinai Hospital to investigate new therapeutic concepts in the field of ubiquitin signalling biology 

Boehringer Ingelheim Announces Successful Resolution of FDA Warning Letter

Boehringer Ingelheim will make detailed clinical trial data available to the scientific community

Response to media coverage on CTV National News

Boehringer Ingelheim pleased with 2013 financial year